Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what extent they may be harmful to a (skin) lesion and its healing process.
Objective: To estimate whether the topical debriding agent, Debrichem, could potentially afford the UK’s National Health Service (NHS) a cost-effective intervention for the management of
All testing was performed in triplicate and testing was completed twice, separated by 2 weeks apart. This was to ensure reproducibility (Parker et al., 2018).
“If biofilms keep chronic wounds from healing, then Debrichem® is the solution” It is with great pride and anticipation that Debx Africa (Pty) Ltd are
This licence authorises manufacture by the licence holder named; if the business should change hands, the company or person taking over the business will have
The licence holder and the persons described and named in Annexure 1 shall at all times ensure that all medical devices distributed, irrespective of its
